CA Patent

CA2621616A1 — Topical gatifloxacin formulations

Assigned to Alcon Research LLC · Expires 2008-08-19 · 18y expired

What this patent protects

Topical ophthalmic solution compositions of gatifloxacin are disclosed. The compositions do not contain disodium edetate or any other metal chelating agent.

USPTO Abstract

Topical ophthalmic solution compositions of gatifloxacin are disclosed. The compositions do not contain disodium edetate or any other metal chelating agent.

Drugs covered by this patent

phentolamine-mesylate (PHENTOLAMINE MESYLATE)

Patent Metadata

Patent number: CA2621616A1
Jurisdiction: CA
Classification: —
Expires: 2008-08-19
Drug substance claim: No
Drug product claim: No
Assignee: Alcon Research LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.